2016
DOI: 10.1016/j.jons.2015.11.010
|View full text |Cite
|
Sign up to set email alerts
|

High-dose vitamin C and cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
31
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(35 citation statements)
references
References 28 publications
0
31
0
1
Order By: Relevance
“…Ascorbic acid (AA) is synthesized from D-glucuronate [1]. In the AA synthesis pathway, L-gulonate is converted to L-gulonolactone by a lactonase called SMP30, whose absence leads to AA deficiency in mice [23].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Ascorbic acid (AA) is synthesized from D-glucuronate [1]. In the AA synthesis pathway, L-gulonate is converted to L-gulonolactone by a lactonase called SMP30, whose absence leads to AA deficiency in mice [23].…”
Section: Discussionmentioning
confidence: 99%
“…Ascorbic acid (AA) is widely known as a water-soluble antioxidant that plays a major role in preventing cellular damage caused by free radicals, highly reactive species leading to cell damage and homeostatic disruption [1]. Various studies have been conducted to investigate the anti-oxidative properties of AA.…”
Section: Introductionmentioning
confidence: 99%
“…High dose Vitamin C in cancer treatment is being debated for a long time (Unlu et al, 2016) but there is a little evidence how does Vitamin C acts against cancer cells. In recent days, there is an increased interest in studying Vitamin C as an adjunct treatment with chemotherapy (Hoffer et al, 2015;Fritz et al, 2014).…”
Section: Discussionmentioning
confidence: 99%
“…However, researchers now suggest that vitamin C prevents cancer by neutralizing ROS before they can damage DNA and initiate tumor growth. Furthermore, it has been proposed that vitamin C may also act as a pro-oxidant, helping the body's own ROS destroy early-stage tumors [27,28]. Currently, the recommended dietary allowance (RDA) in many countries ranges from 40-90 mg/day, although the results of various studies suggesting that the protective vitamin C concentrated in plasma for the minimum risk of free radical diseases corresponds to an intake of 124.2 mg/day (in the range of 92-181 mg) [10,29].…”
Section: Protective Efects Of Vitamin C Against Genotoxic Damage Frommentioning
confidence: 99%